Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangioleiomyomatosis”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableStudy completedNCT02859194
What this trial is testing

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Who this might be right for
Interstitial Pulmonary Fibrosis ARDSCOPD (Chronic Obstructive Pulmonary Disease)Bronchiectasis+3 more
Yonsei University 10
Testing effectiveness (Phase 2)UnknownNCT05190627
What this trial is testing

Effect of Loratadine in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Institut d'Investigació Biomèdica de Bellvitge 62
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Not applicableStudy completedNCT04184193
What this trial is testing

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Who this might be right for
LymphangioleiomyomatosisLAMPulmonary Rehabilitation
Schön Klinik Berchtesgadener Land 58
Not applicableLooking for participantsNCT03193892
What this trial is testing

A National Registry on Chinese Patients With Lymphangioleiomyomatosis

Who this might be right for
Pulmonary Function
Peking Union Medical College Hospital 1,500
Not applicableLooking for participantsNCT02432560
What this trial is testing

Safety and Durability of Sirolimus for Treatment of LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 600
Testing effectiveness (Phase 2)Study completedNCT00792766
What this trial is testing

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous SclerosisAngiolipoma
Children's Hospital Medical Center, Cincinnati 20
Testing effectiveness (Phase 2)Looking for participantsNCT01799538
What this trial is testing

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableEnrolling By InvitationNCT05727852
What this trial is testing

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

Who this might be right for
Chronic Respiratory DiseasesCystic FibrosisLymphangioleiomyomatosis+4 more
I.M. Sechenov First Moscow State Medical University 400
Large-scale testing (Phase 3)Study completedNCT00414648
What this trial is testing

Efficacy and Safety of Sirolimus in LAM

Who this might be right for
Lymphangioleiomyomatosis
University of Cincinnati 89
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03150914
What this trial is testing

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

Who this might be right for
LAMLymphangioleiomyomatosis
University of Cincinnati 60
Early research (Phase 1)Active Not RecruitingNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 155
Very early researchUnknownNCT05087134
What this trial is testing

Characterizing LAM With 11C-Choline PET/CT

Who this might be right for
Lymphangioleiomyomatosis
Peking Union Medical College Hospital 50
Early research (Phase 1)UnknownNCT04273334
What this trial is testing

Application of 68Ga NEB PET Imaging in the Diagnosis and Evaluation of Lymphatic Disorders

Who this might be right for
Lymphatic Disorders
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Study completedNCT03062943
What this trial is testing

Nintedanib for LymphAngioleioMyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis
IRCCS Multimedica 30
Early research (Phase 1)Study completedNCT04388371
What this trial is testing

Glutamine PET Imaging in LAM

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Vanderbilt University Medical Center 5
Load More Results